Haematologica: 96 (2)

January 31, 2011 ; 96 (2)

Editorials and Perspectives

You have access
Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring
Martin Jädersten, Aly Karsan

Haematologica February 2011 96: 177-180; doi:10.3324/haematol.2010.038281
Disclosures
You have access
Myelodysplastic syndromes with bone marrow fibrosis
Matteo Giovanni Della Porta, Luca Malcovati

Haematologica February 2011 96: 180-183; doi:10.3324/haematol.2010.039875
Disclosures
You have access
Pathophysiology of thrombosis in myeloproliferative neoplasms
Raffaele Landolfi, Leonardo Di Gennaro

Haematologica February 2011 96: 183-186; doi:10.3324/haematol.2010.038299
Disclosures
You have access
Macrophages predict treatment outcome in Hodgkin’s lymphoma
Christian Steidl, Pedro Farinha, Randy D. Gascoyne

Haematologica February 2011 96: 186-189; doi:10.3324/haematol.2010.033316

Original Article

Hematopoiesis

You have access
The role of meis1 in primitive and definitive hematopoiesis during zebrafish development
Ana Cvejic, Jovana Serbanovic-Canic, Derek L. Stemple, Willem H. Ouwehand

Haematologica February 2011 96: 190-198; doi:10.3324/haematol.2010.027698
Disclosures and Contributions
Supplementary Appendix
Supplementary Movies

Iron Metabolism

You have access
Iron overload induces BMP6 expression in the liver but not in the duodenum
Léon Kautz, Céline Besson-Fournier, Delphine Meynard, Chloé Latour, Marie-Paule Roth, Hélène Coppin

Haematologica February 2011 96: 199-203; doi:10.3324/haematol.2010.031963
Disclosures and Contributions
Supplementary Appendix

Chronic Myeloid Leukemia

You have access
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate
Serena Giuntoli, Michele Tanturli, Federico Di Gesualdo, Valentina Barbetti, Elisabetta Rovida, Persio Dello Sbarba

Haematologica February 2011 96: 204-212; doi:10.3324/haematol.2010.029082
Disclosures and Contributions
You have access
OCT-1 function varies with cell lineage but is not influenced by BCR-ABL
Jane R. Engler, Andrew C.W. Zannettino, Charles G. Bailey, John E.J. Rasko, Timothy P. Hughes, Deborah L. White

Haematologica February 2011 96: 213-220; doi:10.3324/haematol.2010.033290
Disclosures and Contributions
Supplementary Appendix

Acute Myeloid Leukemia

You have access
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
Brian V. Balgobind, Marry M. Van den Heuvel-Eibrink, Renee X. De Menezes, Dirk Reinhardt, Iris H.I.M. Hollink, Susan T.J.C.M. Arentsen-Peters, Elisabeth R. van Wering, Gertjan J.L. Kaspers, Jacqueline Cloos, Evelien S.J.M. de Bont, Jean-Michel Cayuela, Andre Baruchel, Claus Meyer, Rolf Marschalek, Jan Trka, Jan Stary, H. Berna Beverloo, Rob Pieters, C. Michel Zwaan, Monique L. den Boer

Haematologica February 2011 96: 221-230; doi:10.3324/haematol.2010.029660
Balgobind et al. Supplementary Appendix
Disclosures and Contributions
You have access
Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience
Peter Schellongowski, Thomas Staudinger, Michael Kundi, Klaus Laczika, Gottfried J. Locker, Andja Bojic, Oliver Robak, Valentin Fuhrmann, Ulrich Jäger, Peter Valent, Wolfgang R. Sperr

Haematologica February 2011 96: 231-237; doi:10.3324/haematol.2010.031583
Disclosures and Contributions

Acute Lymphoblastic Leukemia

You have access
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, Heinz-Gerd Derigs, Herve Dombret, Richard Greil, Jesus-Maria Hernández-Rivas, Francoise Huguet, Tamara Intermesoli, Eric Jourdan, Christian Junghanss, Lothar Leimer, Maria-Jose Moreno, Albrecht Reichle, Josep Ribera, Matthias Schmid, Hubert Serve, Matthias Stelljes, Reingard Stuhlmann, Dieter Hoelzer

Haematologica February 2011 96: 238-244; doi:10.3324/haematol.2010.028092
Disclosures and Contributions
You have access
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
Mathilde Hunault-Berger, Thibaut Leguay, Xavier Thomas, Ollivier Legrand, Françoise Huguet, Caroline Bonmati, Martine Escoffre-Barbe, Laurence Legros, Pascal Turlure, Patrice Chevallier, Fabrice Larosa, Frederic Garban, Oumedaly Reman, Philippe Rousselot, Nathalie Dhédin, André Delannoy, Marina Lafage-Pochitaloff, Marie Christine Béné, Norbert Ifrah, Hervé Dombret

Haematologica February 2011 96: 245-252; doi:10.3324/haematol.2010.027862
Disclosures and Contributions
Supplementary Appendix

Malignant Lymphomas

You have access
β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Mona Anand, Raymond Lai, Pascal Gelebart

Haematologica February 2011 96: 253-261; doi:10.3324/haematol.2010.027086
Disclosures and Contributions
Supplementary Appendix
You have access
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children
Ilske Oschlies, Birgit Burkhardt, Itziar Salaverria, Andreas Rosenwald, Emanuele S.G. d’Amore, Monika Szczepanowski, Karoline Koch, Martin L. Hansmann, Harald Stein, Peter Möller, Alfred Reiter, Martin Zimmermann, Angelo Rosolen, Reiner Siebert, Elaine S. Jaffe, Wolfram Klapper

Haematologica February 2011 96: 262-268; doi:10.3324/haematol.2010.030809
Disclosures and Contributions
Supplementary Appendix
You have access
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin’s lymphoma
Peter Kamper, Knud Bendix, Stephen Hamilton-Dutoit, Bent Honoré, Jens R. Nyengaard, Francesco d’Amore

Haematologica February 2011 96: 269-276; doi:10.3324/haematol.2010.031542
Disclosures and Contributions

Chronic Lymphocytic Leukemia

You have access
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group
Stefano Molica, Francesca R. Mauro, Diana Giannarelli, Francesco Lauria, Agostino Cortelezzi, Maura Brugiatelli, Vincenzo Liso, Antonio Cuneo, Robin Foà

Haematologica February 2011 96: 277-283; doi:10.3324/haematol.2010.030189
Disclosures and Contributions

Multiple Myeloma

You have access
Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
Michael. S. van der Veer, Michel de Weers, Berris van Kessel, Joost M. Bakker, Shulamiet Wittebol, Paul W.H.I. Parren, Henk M. Lokhorst, Tuna Mutis

Haematologica February 2011 96: 284-290; doi:10.3324/haematol.2010.030759
Disclosures and Contributions
Supplementary Appendix

Stem Cell Transplantation

You have access
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis
Nicolaus Kröger, Tatjana Zabelina, Anja van Biezen, Ronald Brand, Dietger Niederwieser, Rodrigo Martino, Zi Yi Lim, Francesco Onida, Christoph Schmid, Laurent Garderet, Marie Robin, Michael van Gelder, Reinhard Marks, Argiris Symeonidis, Guido Kobbe, Theo de Witte

Haematologica February 2011 96: 291-297; doi:10.3324/haematol.2010.031229
Disclosures and Contributions
You have access
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
Emilie Castermans, Muriel Hannon, Jacques Dutrieux, Stéphanie Humblet-Baron, Laurence Seidel, Rémi Cheynier, Evelyne Willems, André Gothot, Jean-François Vanbellinghen, Vincent Geenen, Brenda M. Sandmaier, Rainer Storb, Yves Beguin, Frédéric Baron

Haematologica February 2011 96: 298-306; doi:10.3324/haematol.2010.029702
Disclosures and Contributions
Supplementary Appendix

Infectious Disorders

You have access
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host
Hugues de Lavallade, Paula Garland, Takuya Sekine, Katja Hoschler, David Marin, Kate Stringaris, Eva Loucaides, Katherine Howe, Richard Szydlo, Ed Kanfer, Donald Macdonald, Peter Kelleher, Nichola Cooper, Ahmad Khoder, Ian H. Gabriel, Dragana Milojkovic, Jiri Pavlu, John M. Goldman, Jane F. Apperley, Katayoun Rezvani

Haematologica February 2011 96: 307-314; doi:10.3324/haematol.2010.032664
Disclosures and Contributions
Supplementary Appendix

Brief Report

Myeloproliferative Neoplasms

You have access
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
Tiziano Barbui, Alessandra Carobbio, Guido Finazzi, Alessandro M. Vannucchi, Giovanni Barosi, Elisabetta Antonioli, Paola Guglielmelli, Alessandro Pancrazzi, Silvia Salmoiraghi, Pio Zilio, Cosimo Ottomano, Roberto Marchioli, Ivan Cuccovillo, Barbara Bottazzi, Alberto Mantovani, Alessandro Rambaldi

Haematologica February 2011 96: 315-318; doi:10.3324/haematol.2010.031070
Disclosures and Contributions
Supplementary Appendix

Myelodysplastic Syndromes

You have access
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
Gudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, Winfried Hofmann, Hans Heinrich Kreipe, Pierre Fenaux, Eva Hellström-Lindberg, Brigitte Schlegelberger

Haematologica February 2011 96: 319-322; doi:10.3324/haematol.2010.026658
Disclosures and Contributions

Lymphoproliferative Disorders

You have access
Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph
Delphine Casabonne, Oscar Reina, Yolanda Benavente, Nikolaus Becker, Marc Maynadié, Lenka Foretová, Pierluigi Cocco, Anna González-Neira, Alexandra Nieters, Paolo Boffetta, Jaap M. Middeldorp, Silvia de Sanjose

Haematologica February 2011 96: 323-327; doi:10.3324/haematol.2010.031161
Disclosures and Contributions
Supplementary Appendix

Multiple Myeloma

You have access
CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features
Martin Schmidt-Hieber, Martin Pérez-Andrés, Bruno Paiva, Juan Flores-Montero, Jose J. Perez, Norma C. Gutierrez, Maria-Belen Vidriales, Sergio Matarraz, Jesus F. San Miguel, Alberto Orfao

Haematologica February 2011 96: 328-332; doi:10.3324/haematol.2010.031872
Disclosures and Contributions
Supplementary Appendix
You have access
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients
Maurizio Zangari, Shmuel Yaccoby, Lisa Pappas, Federica Cavallo, Naveen Sanath Kumar, Subramanian Ranganathan, Larry J. Suva, J. Michael Gruenwald, Steven Kern, Fenghuang Zhan, Dixie Esseltine, Guido Tricot

Haematologica February 2011 96: 333-336; doi:10.3324/haematol.2010.031302
Disclosures and Contributions

Infectious Disorders

You have access
Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study
Caroline Even, Sylvie Bastuji-Garin, Yosr Hicheri, Cécile Pautas, Francoise Botterel, Sébastien Maury, Ludovic Cabanne, Stéphane Bretagne, Catherine Cordonnier

Haematologica February 2011 96: 337-341; doi:10.3324/haematol.2010.030825
Disclosures and Contributions

Letters to the Editor

Myeloproliferative Disorders

You have access
ETV6-ABL1-positive “chronic myeloid leukemia”: clinical and molecular response to tyrosine kinase inhibition
Fabiana Perna, Omar Abdel-Wahab, Ross L. Levine, Suresh C. Jhanwar, Kazunori Imada, Stephen D. Nimer

Haematologica February 2011 96: 342-343; doi:10.3324/haematol.2010.036673
Disclosures and Contributions

Malignant Lymphomas

You have access
Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas
Clare Bedwell, David Rowe, Deborah Moulton, Gail Jones, Nick Bown, Chris M. Bacon

Haematologica February 2011 96: 343-346; doi:10.3324/haematol.2010.031484
Disclosures and Contributions

Online Only Articles

You have access
Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
Khaled M. Musallam, Ali T. Taher

Haematologica February 2011 96: e5-e6; doi:10.3324/haematol.2010.036061
Disclosures and Contributions
You have access
Deferiprone or deferasirox for cardiac siderosis in β thalassemia major (reply)
Alessia Pepe, Giuseppe Rossi, Antonella Meloni, Aurelio Maggio

Haematologica February 2011 96: e7-e8; doi:10.3324/haematol.2010.039479
Disclosures and Contributions
You have access
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients
Catherine Cordonnier, Montserrat Rovira, Johan Maertens, Oliver A Cornely, Per Ljungman, Hermann Einsele

Haematologica February 2011 96: e9-e10; doi:10.3324/haematol.2010.038463
Disclosures and Contributions
You have access
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients (reply)
Corrado Girmenia

Haematologica February 2011 96: e11; doi:10.3324/haematol.2010.038810
Disclosures

Table of Contents

Editorials and Perspectives

Original Article

Hematopoiesis

Iron Metabolism

Chronic Myeloid Leukemia

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Malignant Lymphomas

Chronic Lymphocytic Leukemia

Multiple Myeloma

Stem Cell Transplantation

Infectious Disorders

Brief Report

Myeloproliferative Neoplasms

Myelodysplastic Syndromes

Lymphoproliferative Disorders

Multiple Myeloma

Infectious Disorders

Letters to the Editor

Myeloproliferative Disorders

Malignant Lymphomas

Online Only Articles

In this issue

Table of Contents

Editorials and Perspectives

Original Article

Hematopoiesis

Iron Metabolism

Chronic Myeloid Leukemia

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Malignant Lymphomas

Chronic Lymphocytic Leukemia

Multiple Myeloma

Stem Cell Transplantation

Infectious Disorders

Brief Report

Myeloproliferative Neoplasms

Myelodysplastic Syndromes

Lymphoproliferative Disorders

Multiple Myeloma

Infectious Disorders

Letters to the Editor

Myeloproliferative Disorders

Malignant Lymphomas

Online Only Articles

In this issue

Jump to